Exousia Bio (LMMY) Equity Ratio (2023 - 2025)
Lamy (LMMY) has disclosed Equity Ratio for 3 consecutive years, with 0.99 as the latest value for Q4 2025.
- Quarterly Equity Ratio fell 1.18% to 0.99 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.99 through Nov 2025, down 1.18% year-over-year, with the annual reading at 2.0 for FY2024, 154.65% down from the prior year.
- Equity Ratio hit 0.99 in Q4 2025 for Lamy, down from 1.0 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 1.0 in Q4 2024 to a low of 2.1 in Q3 2024.
- Historically, Equity Ratio has averaged 0.97 across 3 years, with a median of 1.54 in 2023.
- Biggest YoY gain for Equity Ratio was 159.66% in 2024; the steepest drop was 154.65% in 2024.
- Year by year, Equity Ratio stood at 1.68 in 2023, then soared by 159.66% to 1.0 in 2024, then dropped by 1.18% to 0.99 in 2025.
- Business Quant data shows Equity Ratio for LMMY at 0.99 in Q4 2025, 1.0 in Q4 2024, and 2.1 in Q3 2024.